A clinical exome sequencing report identifies a variant of uncertain significance (VUS) in KCNQ2 in a 3-month-old infant with neonatal-onset epilepsy. The infant's seizures are well controlled on carbamazepine. During counseling, the parents ask whether this VUS confirms their child's diagnosis. What is the most appropriate counseling approach?